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In general there is a growing demand for fertility treatment. On the one hand, 
this results from the fact that reproductive technologies are becoming estab-
lished procedures and correspondingly their acceptance is increasing. On the 
other hand, there are indications that an increasing proportion of couples pres-
ent fertility disturbances. The causes may lie in a general increase in risk factors, 
such as environmental burdens, an unhealthy life style, and urogenital infections 
and diseases. A significant reason is also, however, that couples increasingly 
postpone satisfaction of their desire to have children until a later phase of life, 
in which natural fertility (in particular of women) has declined considerably and 
a pregnancy is linked to increased risks to the health of mother and child. The 
idea that the time constraints on reproduction might be removed arises against 
the background of more and more frequent reports about women aged 40 and 
above who are apparently in the prime of life and who are expecting their first 
child. Two issues that are frequently not a topic of discussion are (1) that many 
couples have to engage the help of reproductive medicine, and (2) how many of 
them ultimately fail to have children despite having undergone repeated in vitro 
fertilization procedures.
Reproductive medicine provides the technical medical options for dealing with 
this unsatisfied desire to have children. Reproductive medicine (also called as-
sisted reproductive techniques, or ART) refers to all of the treatments and proce-
dures for handling human oocytes, sperm, or embryos with the goal of bringing 
about a pregnancy and the birth of a child. There have been significant devel-
opments in reproductive medicine in the last few years. In addition to in vitro 
fertilization (IVF), it today includes intracytoplasmatic sperm injection (ICSI) 
into an oocyte with subsequent transfer of the embryo, as well as cryopreserva-
tion of gametes, impregnated egg cells, and embryos and their later use in assist-
ed reproduction. Although reproductive medicine was initially directed at the 
treatment of infertility in women which was organic in nature, further specific 
techniques have been and are being developed that apply to all forms and causes 
of a couple’s infertility.
The procedures in assisted reproduction are however also tied to various diffi-
culties. One can name in particular the health risks to women and to the chil-
dren conceived in this way as well as the psychic stress on the parties involved 
before, during, and after treatment (especially if the measure is unsuccessful). 
The most important parameter of success is the probability of the birth of a 
child per treatment cycle, the baby-take-home rate (BTHR). Worldwide the rate 
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is 20%–25% and thus of the magnitude that is assumed to be the birth rate after 
natural conception. The age of the woman exerts a great influence on the birth 
rate: the older, the lower. The current goals include especially raising the efficacy 
of technically assisted reproductive techniques (e. g., by means of a better tar-
geted preselection of the transferred embryos) and lowering the risks for women 
and children, particularly by reducing the number of pregnancies with multiple 
fetuses, which always pose a health risk and often cause psychosocial stress.
ART IN CLINICAL PRACTICE: SUCCESSES AND PROBLEMS
The use of reproductive medicine in Germany is subject to the Embryo Protection 
Law (Embryonenschutzgesetz, ESchG), adopted in 1991. It permits only those 
oocytes to be transferred that stem from the patient herself. Egg donation and 
surrogate motherhood are not permitted, while semen donation is. Furthermore, 
a maximum of three embryos may be transferred to the womb at one time, and 
a selection among the oocytes is only possible during the initial 24 hours after 
impregnation, i. e., before nuclear fusion.
In European comparison, reproductive medicine treatment is conducted in Ger-
many less frequently than the average of the other countries. The percentage 
of births is also below the European average. Yet if one considers the data for 
treatments and births for the year 2003 (before the Health Care Modernization 
Law took effect), Germany was above the European average. This makes it clear 
that the below average treatment numbers for Germany cannot be traced back 
to a lack of medical know-how or to missing social acceptance, but primarily 
to the health policy framework. After the health care reform took effect, there 
was a nearly 50% drop in treatment numbers in 2004. Since then there has been 
a slow but steady increase. This development, by the way, corresponds to the 
global situation, namely that the number of ART cycles carried out is directly 
related to the financing by the health care system.
At the same time, an increase in the age of patients can be observed even though 
the financing by the statutory health insurance companies in Germany is subject 
to an age restriction. This must be seen in the context that the average age of 
first-time mothers in Germany – as in almost all industrial nations – is in general 
increasing. The proportion of women over 35 who undergo IVF or ICSI therapy 
in Germany is higher than the European average (in 2005, in Germany 55.6% 
of the women undergoing IVF were 40 or older, while in Europe as a whole the 
value was 50.5%). This development must be seen critically in view of the fact – 
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especially for woman over 35 – that the prospects for a successful conception, 
pregnancy, and birth decline rapidly.
With regard to the techniques that are employed, an increased use of ICSI tech-
niques can be seen in Germany, just as in Europe, the USA, and the world as a 
whole. While conventional IVF treatments still account for approximately one 
third of all treatments in Germany, IVF is used less frequently in many Europe-
an countries. This development cannot be explained by the significantly higher 
success rates of ICSI since the latter only promises to be more successful than 
conventional IVF in cases where the quality of the man’s sperm is limited. The 
increase in number of ICSI treatments might be explained by the fact that male 
infertility has today become an increased focus of attention among specialists in 
reproductive medicine.
A development that can be observed throughout Germany, Europe, and the 
world is that fewer embryos are being transferred pro cycle. This has to be seen 
in the context of improved technical possibilities in ART applications since the 
prospects of success have improved for all of the methods employed in Germany. 
Furthermore, the goal of treatments in reproductive medicine is increasingly to 
prevent a pregnancy with multiple fetuses. A policy of single embryo transfer 
(SET) is becoming increasingly prevalent, especially in the Scandinavian coun-
tries. Leading the way is Sweden, where predominantly only a single embryo is 
transferred, which is also reflected in the highest rate of singletons in Europe. 
Because of the partially elective character of SET, which is only permitted in 
Germany under specific conditions, Germany is in the middle of the field in Eu-
rope with regard to the number of transferred embryos and of pregnancies with 
multiple fetuses. Mainly, two embryos are transferred.
The trend to transferring fewer embryos suggests that in Germany, too, there are 
efforts to minimize the risk of a pregnancy with multiple fetuses, in particular 
one involving several embryos. The SET rate in Germany has correspondingly 
continued to increase (between 2003 and 2008 its relative portion of all ART 
treatments rose from 11% to 13.3%), although the prospects of success are 
significantly lower than if two embryos are transferred. The transfer of a single 
embryo continues, however, to be the exception. Nonetheless, the tendency for 
fewer embryos to be transferred has led to a decrease in the number of multiple 
births throughout Europe and in the USA. In this sense, the policy of SET can 
be considered to be a success. The rates of multiple births in Germany and in 
most of the European countries are still, however, clearly higher than the rate to 
be expected naturally. Sweden is the sole European country in which the ART 
singleton rate is higher than 93% (an almost natural rate).
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The success rates for the baby-take-home rate (BTHR), i. e., the birth rate per 
cycle, in Germany in the period from 1997 to 2005 were below the European 
average. In general, a comparison is difficult since there are differences in how 
the data are collected in the individual countries and some of the data are in-
complete. If one considers the BTHR for Germany and Europe, Germany’s rate 
of 15.4% corresponds largely to the European average of 15.0%. Yet if only 
those countries whose data for all ART treatments is available and complete 
are included in the European average, then the average BTHR is 16.8%. Of 
these countries, Great Britain has the highest rate of success at 20.4%, closely 
followed by the Scandinavian countries among others.
Overall we must recognize that use of ART to treat unwanted childlessness is 
being conducted more and more frequently in Germany, Europe, and the USA 
and that there has been a considerable improvement in the prospects of success 
for affected couples in the last few years. Internationally, however, the number of 
ART cycles that have been carried out in Germany and the number of births that 
result are below the European average. We must note in this context, however, 
that for many years the focus of assisted reproduction was nearly exclusively 
on maximizing the effectiveness of the treatment as reflected by the indicator 
BTHR. The high success rates were achieved at the expense, however, of obtain-
ing as many oocytes per cycle as possible in order to be able to transfer as many 
embryos as possible into the uterus. This resulted in the danger of ovarian hyper-
stimulation syndrome and a high number of pregnancies with multiple fetuses 
with the concomitant health risks and stress. Some ten years ago, the increased 
use of elective SET led to a change in policy, which is currently being further 
developed under the designation of a »patient friendly« or »patient centered« 
approach to reproductive medicine. This concept includes in particular the ob-
jectives of minimizing the general stress and health risks to women, children, 
and men.
PSYCHOSOCIAL COUNSELING CONCOMITANT TO FERTILITY 
TREATMENT
The diagnosis of a fertility disorder pushes many couples to the limits of their 
ability to cope with emotional stress. Studies show that infertility can constitute 
one of the most stressful situations in life, comparable to the loss of a partner 
or the death of a child. It should also be noted that, as a rule, the role played 
by psychic causes in connection with an unsatisfied desire to have children are 
considerably overestimated. At the same time, the consequences of both the un-
satisfied desire for children and the treatment in reproductive medicine are still 
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frequently underestimated. Although there have been far-reaching developments 
and improvements in the technical steps in the medical procedures, the psy-
chosocial aspects of stress related to an unsatisfied desire for children during 
treatment and after an unsuccessful treatment have hardly changed. One can, 
however, understand the changes in how couples who are involuntarily childless 
are treated in a medical context. Emphasis can in particular be placed on the 
strengthening of psychosomatic forms of treatment and the depathologization 
of couples. What is referred to as psychosomatic primary care, which has also 
increasingly established itself in reproductive medicine in the last few years, has 
proven itself to be sensible since it integrates psychic and social factors in treat-
ment in addition to the medical ones.
Overall, psychosocial counseling of involuntarily childless couples should offer 
help toward deciding about pending therapeutic measures but also support in 
dealing with conflicts between a couple that result from this stressful situation. It 
should furthermore help the couple improve its communication with one anoth-
er, with physicians, and with their environment in order for it to cope with the 
situation in a more adequate manner. Another important aspect is to promote 
the acceptance of a life without biological children and to include the possibility 
of treatment being unsuccessful in the counseling from the beginning. Yet even 
if counseling is available, there are still informational deficits and anxiety about 
accepting help as well as anxiety about being stigmatized by their social environ-
ment if such help is accepted. This explains the fact that only a small portion of 
couples actually accept psychosocial counseling about their desire to have chil-
dren although a large number of these couples have a positive attitude toward it. 
The acceptance rates are however much higher (up to 80%) when psychosocial 
counseling about a couple’s desire to have children is an integral and accepted 
component of the treatment.
Counseling in connection with gamete donation
Although only semen donation is permitted in Germany, experts advise against 
limiting counseling to this form of gamete donation (i. e., of semen, oocytes, or 
embryos), precisely in the context of the increase in reproductive traveling. A 
more binding form of counseling should be established, introducing a require-
ment that participation in counseling or its rejection be documented. The reason 
for this is that the creation of a family on the basis of donated gametes results 
in specific issues that differ from those associated with the creation of a family 
on the basis of a couple’s own gametes. The acceptance of gametes from third 
persons leads to biological and social parentage. This usually has far-reaching 
and profound consequences for all the participants: the parents who wanted a 
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child, the child conceived in this manner, the donor and his or her partner, the 
parents of the new parents and of the donor, and any other children of these 
parents or the donor, regardless of whether they were born previously or later. 
In order to take the welfare of all the participants – especially that of the child to 
be conceived in this manner – into consideration as well as possible, a decision 
in favor of gamete donation should be based on informed consent that takes 
both the momentary as well as the long-term implications of this manner of 
creating a family into account for all of the participants. The counseling should 
be conducted by qualified professionals before the beginning of the medical in-
tervention. It should be presented as a constructive process of examining a type 
of family that deviates from the customary norm and about which there is little 
educational literature available. The counseling should fill any gaps in informa-
tion and support those seeking advice in their process of coming to grips with 
social and biological parentage.
LEGAL ASPECTS
Reproductive medicine in Germany is thoroughly structured by a dense network 
of various coactive rules that are scattered in different laws and regulations. The 
result is a degree of confusion. This confusion is however not (exclusively) re-
sponsible for the existing legal uncertainty in the area of reproductive medicine, 
which is rather due to the fact that certain rules possess general applicability for 
different areas of medicine. Even a tendency toward creating special legal rules 
can be noted, which contributes to the confusion and contradictions. In this 
situation, the question is whether a separate law for reproductive medicine is 
necessary and also suitable for unequivocally overcoming the uncertainties and 
contradictions. On the other hand, the law governing reproductive medicine is 
characterized in part by considerable legal uncertainty with regard to various 
new techniques as a result of various unclarities or ambiguities in the Embryo 
Protection Law. It appears necessary for the unclarities to be resolved so that 
state-of-the-art specialist standards can be provided in the area of reproductive 
medicine in the future.
The newest development and one that is also relevant in Germany is the recent 
decision of the European Court of Human Rights on the Austrian law on repro-
ductive medicine. It could lead to new movement in the discussion. In its deci-
sion, the European Court of Human Rights affirms that all limiting or restricting 
legal regulations are subject to rigorous checks as to whether they are com-
mensurate. In the process, this court expresses its opinion that reasons based in 
moral considerations or social acceptance do not on their own provide sufficient 
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cause to completely prohibit a technique of reproductive medicine. Fundamental 
for the decision were, in particular, the obvious judgmental contradictions be-
tween certain prohibited and permitted measures.
It might even be possible to clarify some of the uncertainties in the Embryo 
Protection Law, possibly even today, by appropriate interpretation. These pos-
sibilities are used by parts of the judicature and law. It is possible to detect 
an increasing tendency on their part to take the current medical and scientific 
developments and the overwhelmingly positive attitude of society toward re-
productive medicine into consideration and to interpret the rules in the Embryo 
Protection Law – where this is possible – in a more comprehensive sense. Yet 
the situation remains uncertain for physicians and patients as long as there is no 
decision from the highest court to all of the unclear legal issues.
Legal aspects in international comparison
An overview of an international comparison of the medical-technical procedures 
in reproductive medicine shows that – although these procedures are essential-
ly the same – neither reproductive medicine nor couples desiring children can 
make use of the procedures in the same manner. Overall one can say that the 
regulations in Europe are very diverse. They are based on different historical 
developments and different cultural, religious, social, political, and economic 
factors. Efforts have been and are being made at the European level to harmo-
nize these differences. The European Court of Human Rights in particular plays 
an important role in this context, as shown by its decision of April 1, 2010, in 
which the prohibition of oocyte and semen donation is called an infringement 
of the prohibition of discrimination. It is evident that this pushed the door wide 
open for the possible or necessary regulatory changes in the area of reproductive 
medicine not just in the Austria, the country directly affected by the judgment, 
but in other countries as well. After all, the European Union plays an important 
role in legal harmonization – as shown for example in Article 12 of the EU di-
rective on human tissue and cells 2004/23/EU – one of the purposes of which 
is to coordinate medically assisted reproduction. This is of immediate relevance 
for preimplantation genetic diagnosis, semen and oocyte donation, and the cry-
opreservation of embryos. In this connection, internationally active nongovern-
mental organizations, such as the European Society of Human Reproduction 
and Embryology (ESHRE), play a role since they have been trying – some for 
several decades – to set scientific and professional standards and to support the 
policies surrounding research on and the practical implementation of the tech-





Enlightening the general public about the reproductive phase and about the lim-
itations on options with advancing age is of great significance. This enlighten-
ment should already be initiated in school sex education. The rising age of first 
gravidity means not only that the probability of having a second or third child 
is sinking but that more and more frequently this is also true about a first child. 
In contrast to this is the promise held by reproductive medicine that the desire to 
have children can be fulfilled anytime and that reproductive medicine is better 
than nature. The success rates of treatments in reproductive medicine must be 
presented more clearly. Furthermore, the aspects represented by cost and effort 
and by success and general results should be communicated more forcefully.
It is possible to name the following aspects of sensible adjunctive psychoso-
cial counseling during fertility treatment. Every couple should fundamentally 
be able to make use of psychosocial counseling at any time during fertility 
treatment, which should also act to remove thresholds. The obligatory part 
of the (standardized) qualification of the psychosocial counselors should in-
clude experience in couples counseling, awareness of the psychosocial factors 
in unwanted childlessness, and knowledge about the current state of ART. 
The counseling being offered should be made available independently of the 
reproductive medicine centers, but in cooperation with them. The psychoso-
cial counseling should take place before the planned measures, including any 
time allotted for the couple to consider them. It should also as a matter of 
principle be available before, during, and after all the measures of medically 
assisted reproduction. The implementation of the directive issued by the Ger-
man Medical Association (Bundesärztekammer) should be effectively guaran-
teed in practice in each reproductive medicine center, including with regard to 
the psychosocial aspects. This directive should furthermore be revised to take 
better consideration of the psychosocial aspects of assisted reproduction. Yet 
the task is fundamentally to simplify and increase the precision of the partial-
ly contradictory directives of the German Medical Association, the German 
social security code (SGB), and the German Society for Fertility Counseling 
(Beratungsnetzwerk Kinderwunsch in Deutschland, BKiD).
Integration and networking of counseling
Currently psychosocial counseling generally takes place separately from that in 
reproductive medicine, which leads to unnecessary duplications and disparities 
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between fertility treatment and psychological counseling, which in turn is an 
irritation to couples. This could be avoided by an improved coupling of the psy-
chosocial counseling with the treatment in reproductive medicine, and the pro-
fessional competence of the counselors and therapists could be better utilized. 
And the current situation that many couples either do not know about the op-
tion of psychosocial counseling or find out about it very late could be improved 
and the gap between need for counseling and its use could be minimized. Finally, 
but not least important – in particular considering the fact that reliable, highly 
professional quality is necessary and that these professionals must take part in 
ongoing training – it would be sensible to conduct a scientific evaluation of the 
psychosocial counseling for the desire to have children.
Risk reduction
One of the factors that currently lowers the prospects of success in Germany is 
that the (average) age of ART patients has increased significantly and continues 
to rise. For the affected couples it would be practical if ART treatment were ini-
tiated as early as possible since the chances of success are significantly better for 
younger women and thus in most cases a pregnancy and birth of a child could be 
reached with a smaller number of cycles. This would coincide with less personal 
stress for the couples and with lower treatment costs.
In the course of a stronger patient-oriented treatment in reproductive medicine, 
the future significance of the following factors (among others) would have to be 
examined:
 > Modification of the process organization of IVF clinics in order to lower the 
stress that couples experience during the treatment in reproductive medici-
ne and to reach a stronger focus on the patients. There is clear potential for 
improvement by avoiding the frequent change in medical personnel during a 
couple’s course of treatment, by informing couples better about all the details 
of the treatment, and by providing them stronger emotional support.
 > Optimization and simplification of the administration of gonadotropin in or-
der to reduce patient stress; close monitoring of ovarian stimulation and oocy-
te maturation in order to prevent ovarian hyperstimulation syndrome. There 
is also a need to clarify whether the use of in vitro maturation constitutes a 
further option for being able to use oocytes that have not matured optimally.
 > Avoiding pregnancies with multiple fetuses by transferring only one embryo. 
A prerequisite for this is the availability of methods for evaluating the quality 




 > Making greater use of cryopreservation of oocytes, impregnated oocytes, or 
embryos is necessary to achieve cumulative pregnancy rates that are as high 
as possible.
In general, there is a need for evidence-based research projects on currently 
pending problems or on specific aspects of ART. The study of the safety, risks, 
and consequences of techniques of reproductive medicine has not been pursued 
internationally with the same dynamics and intensity as the development of ex-
isting or new ART techniques. On the basis of newly acquired information, 
future questions should be pursued in a more differentiated manner, and studies 
should be methodologically better planned. Overall, high-quality studies contin-
ue to be necessary in order to answer open questions:
 > Large-scale (representative, multicenter) prospective studies with control 
groups that take into consideration socioeconomic factors and the base health 
status of the couple considering fertility treatment (e. g., history and course of 
infertility).
 > Studies on the safety of new techniques and biological mechanisms that go bey-
ond the perinatal phase, in particular cryopreservation, vitrification, in vitro 
maturation of oocytes, use of sperm from testicular sperm extraction (TESE), 
embryo biopsies, and oocyte and semen donation.
 > Studies with control groups made up of children who were conceived naturally 
and whose parents had to wait just as long for a pregnancy as couples undergo-
ing ART treatment. Such studies should make possible greater differentiation 
with regard to the extent to which parental infertility or the ART procedure 
contributes to an increased risk of illness.
 > Studies on the long-term development of ART children that continue into 
adulthood, especially on the risks for illnesses that do not become manifest 
until advanced age (e. g., diabetes, cardiovascular illnesses, malignant diseases).
There is also a need for research with regard to the sociopsychological devel-
opment of children and family dynamics following a successful treatment. For 
example, the psychological effects of higher rates of preterm births and lower 
weight at birth after ART, even of singletons, and the effects of secondary dam-
age are not yet known. This should be examined in prospective studies on child 
and family development. Furthermore, in view of the fact that the male offspring 
following ICSI treatment of a father with inherited infertility will also be infer-
tile, it is very important that prospective studies be conducted until the children 
reach the stage of family planning. From a psychological point of view, these 
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boys must be given timely information. After all, the children conceived with the 
aid of assisted reproduction are generally informed very late – if at all – about 
the mode of their conception, and those after semen or oocyte donation hardly 
at all. It is unknown what this means for the development of these children.
Research into adoption and on identifiable donors points so far to the impor-
tance of knowledge about biological roots. According to the current state of 
research, an anonymous gamete donation must be considered rather critically 
from a psychological point of view, and research in this area at least has to be 
intensified. As a rule, children conceived in connection with a gamete donation 
or a surrogate mother in another country do not have the possibility of getting to 
know their biological roots. The long-term significance of this for children and 
their families should be studied. In Germany in the last few years, a few isolated 
children have sought or even established contact to a semen donor. The objective 
here is initially to evaluate the experience of the children, their parents, and the 
donors qualitatively and also – if there are larger numbers – quantitatively. This 
will help create a structure of such contacts for psychosocial care.
Financing
Financing is apparently of great significance in the perception of offers for treat-
ment in reproductive medicine. Cuts in the amounts paid for this treatment by the 
statutory health insurance companies have led to a clear decline in the number of 
treatments performed. There was an obvious decline in how many reproductive 
medicine measures were performed in Germany in 2004, when the statutory 
health insurance companies introduced a significantly more restrictive policy for 
covering expenses. Since then, at constant financing conditions, the number of 
ART treatments has been increasing slowly but constantly. Against this back-
drop, it can be assumed that some of the so-called reproduction tourism does 
not take place only because of a country’s rather »liberal« policy toward meas-
ures in reproductive medicine – for example to countries such as Belgium, the 
Czech Republic, and Spain – but that increasingly cost factors also play a role, 
such as in the case of such trips to, for example, Slovenia, Hungary, or Ukraine. 
This will be all the more the case if, as agreed at the European level, medical care 
will actually be available to all EU citizens in all the European countries.
Finally, it also appears noteworthy that the offers of psychological counseling 
are being accepted for payment by the statutory health insurance companies, 
at least for a limited number of sessions. In view of the cost issue raised in this 
connection, it should be pointed out that psychosocial counseling regarding a 
desire to have children does not have a preferred outcome. It can contribute to 
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stabilizing emotionally unstable couples who have a good pregnancy prognosis, 
so that they can undertake what is – from a medical point of view – a sensible 
number of treatment cycles. It can also support couples who have made a deci-
sion against (further) expensive measures in reproductive medicine.
Legal adjustments
With reference to the recent decisions of the European Court of Human Rights, 
some of the prohibitions contained in the German Embryo Protection Law could 
also be considered in violation of the European Convention on Human Rights. 
The European Commission on Human Rights and the relevant decisions of the 
European Court of Human Rights apply in German jurisdiction in the same 
manner that a federal law does. In interpreting the European Court on Hu-
man Rights, the administrative bodies and the courts (and even the legislature) 
are therefore called upon – under certain preconditions – to take the European 
Commission on Human Rights into account in their decisions and interpretation 
of national regulations. A reform of the laws covering reproductive medicine – 
or at least of individual norms of the Embryo Protection Law – might therefore 
be necessary. This view is also supported by the German Federal Court of Justice 
(Bundesgerichtshof, BGH). In its decision of July 6, 2010, this body noted criti-
cally that the German legislature did not determine an explicit regulation in the 
Genetic Diagnosis Act or the Embryo Protection Law, nor in the relevant legis-
lative material, regarding the permissibility of preimplantation genetic diagnosis 
despite being aware of the conflicts about this topic that have been ongoing for 
many years. For this reason, the Federal Court of Justice added a reminder that 
an unambiguous legal regulation of the matter was still necessary. If the judg-
ment of the European Court of Human Rights is confirmed, this would also be 
relevant for the German legislature.
A review of the legal situation in Germany thus appears sensible or necessary 
regarding the following existing unclear issues:
 > What is supposed to happen with the »extra« embryos collected for IVF (e. g., 
cryopreserved) or SET and that will no longer be utilized for reproductive pur-
poses? May they possibly be donated or used for research purposes?
 > How can unwanted pregnancies with multiple fetuses be prevented? Should 
elective single embryo transfer be permitted?
 > From ethical and legal points of view, how are we to proceed with »extra« fe-
tuses (where there are health or medical issues during pregnancy)?
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In the context of the judgment of the Federal Court of Justice on the culpability 
of PGD, the review of the legal situation in Germany also appears necessary in 
view of the following unclear issues:
 > Should PGD also be expressly forbidden on nontotipotent cells? If not, which 
examinations of which genetic properties or dispositions to illnesses should be 
permitted in the framework of PGD of nontotipotent cells?
 > Should PGD be completely included in the applications covered by the Genetic 
Diagnosis Act? If yes, which changes will be necessary?

The Office of Technology Assessment at the German Bundestag is an independent scientific 
institution created with the objective of advising the German Bundestag and its committees on 
matters relating to research and technology. Since 1990 TAB has been operated by the Institute 
for Technology Assessment and Systems Analysis (ITAS) of the Karlsruhe Institute for Technol-
ogy (KIT), based on a contract with the German Bundestag
OFFICE OF TECHNOLOGY ASSESSMENT
AT THE GERMAN BUNDESTAG
